Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-16-006301

Options or other derivatives

  • CHIEF MEDICAL OFFICER acquired 180,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Smith Mark Alan CHIEF MEDICAL OFFICER 2016-06-19 Grant or award · Stock Option (Right to Buy) +180,000 180,000 D
Loading xslF345X03/form4-06212016_060609.xml…